A. To meet the recommended cut-off value of 0.15 two pr three genes would be satisfactory for normalization.
Figure 2 Protein Tyrosine Kinase inhibitor NormFinder analysis of the candidate reference genes. Genes are presented in an increasing order of stability from left to right with B2M as the least stable gene and RPLP0 as the most stable gene. Due to different ranking by geNorm and NormFinder of the most stable genes, cycle threshold coefficient of variation (CtCV%) was calculated for each of them. Evofosfamide solubility dmso This calculation was recommended by Caradec et al., 2010, in order to validate the NormFinder and geNorm results . According to the CtCV% calculation, one of the NormFinder pairing genes, IPO8, was ranked as the most stable gene with a CtCV% of 5.12%, which supports the NormFinder result. GUSB (5.5%) and HPRT1 (6.04%) are ranked as the second and third respectively, which do not
give identical ranking of results obtain using geNorm and see more NormFinder. The least stable gene using CtCV% was 18S (14.99%), which was according to geNorm and NormFinder ranked as the second and fifth least stable gene, respectively. The summary of the best ranking genes as determined by each of these calculations is illustrated in Table 4. Table 4 Ranking and best combination of reference genes determined by geNorm, NormFinder and CtCV%. Rank GeNorm NormFinder CtCV% 1 HPRT1 RPLP0 IPO8 (5.12) 2 PPIA TBP GUSB (5.55) 3 PGK1 GUSB HPRT1 (6.04) 4 RPLP0 POLR2A HMBS (6.23) 5 HMBS IPO8 TBP (6.38) 6 GAPDH GAPDH POLR2A (6.54) 7 GUSB PPIA UBC (6.60) 8 IPO8 HPRT1 YWHAZ (6.86) Best gene/combination HPRT1/PP1A IPO8/PPIA IPO8 Discussion qRT-PCR has been a breakthrough for the quantification of gene expression in many biological systems. In this study we assume that no single gene stays unaffected under malignant development in colon cancer and therefore identify genes with least variation.
We identified two pairs of genes, HPRT1/PPIA and IPO8/PPIA, which may be suitable to normalize gene expression data in studies conducted in metastatic and non-metastatic colon cancer patients. In addition, we found that B2M, ACTB and 18S were unstable in the tissue examined. We propose a standardized approach of finding the most suitable reference gene(s) Ibrutinib clinical trial in every qRT-PCR experiment using TLDA. Complex signalling pathways have been related to the metastatic progression of colon cancer, hence pathway based gene expression assays, often revealed by qRT-PCR, are significant in cancer biology. Publications dealing with colon cancer have reported gene expression studies in metastatic diseases [34, 35]. However, the stability of the reference gene expression in metastatic and non-metastatic primary tumours remains crucial. Ramaswamy et al., 2003, described a gene expression signature that distinguished primary and metastatic adenocarcinomas, indicating that the metastatic potential of human tumours is encoded in the bulk of the primary tumour , fully in accordance with modern clonal stem cell theories .